Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Optic Neuritis
80%
Multiple Sclerosis
73%
Multiple Sclerosis Diagnosis
45%
Outer Retina
40%
Hyperreflective Dots
40%
Relapsing-remitting multiple Sclerosis
40%
Hyperreflective Foci
40%
Avascular
40%
Disease Severity
40%
Normal-appearing White Matter
40%
Blood-brain Barrier Permeability
40%
Relation to Disease
40%
Cerebrospinal Fluid
40%
Neurofilament Light (NF-L)
40%
Predictive Ability
40%
2017 McDonald Criteria
28%
Outer nuclear Layer
25%
Retina
20%
Dissemination in Space
17%
Optical Coherence Tomography
15%
De Novo Identification
13%
High Normal
11%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
MRI Criteria
11%
Retinal Nerve Fiber Layer Thickness (RNFLT)
11%
Contrast-enhancing Lesions
11%
Spearman
11%
Interocular Difference
11%
Retinal Nerve Fiber Layer
10%
Multiple Sclerosis Treatment
10%
B-scan
10%
Hyperreflective
10%
In Vivo Quantification
5%
Imaging Criteria
5%
Imaging Biomarkers
5%
Diagnostic Parameters
5%
Color Vision
5%
Diagnostic Samples
5%
Potential Biomarkers
5%
Dissemination in Time
5%
Potential Loss
5%
Patlak Model
5%
Clinical Application
5%
Clinically Isolated Syndrome
5%
Oligoclonal Bands
5%
Visual Acuity
5%
Minimum Follow-up
5%
Early multiple Sclerosis
5%
Observation Time
5%
Immunology and Microbiology
Multiple Sclerosis
80%
Optic Neuritis
80%
Diagnosis of Multiple Sclerosis
45%
Cerebrospinal Fluid
40%
Metagenome
40%
White Matter
40%
Blood Brain Barrier
40%
Neurofilament Light Chain
40%
Magnetic Resonance Imaging
34%
McDonald Criteria
28%
Metagenomics
26%
Microbiome
26%
Cladistics
26%
Retinal Nerve Fiber Layer
17%
Contig
13%
Oligoclonal Band
5%
Visual Acuity
5%
Clinically Isolated Syndrome
5%
Color Vision
5%
Neuroscience
Multiple Sclerosis
100%
Optic Neuritis
80%
Diagnosis of Multiple Sclerosis
45%
Blood Brain Barrier
40%
Neurofilament Light Chain
40%
Relapsing Remitting Multiple Sclerosis
40%
Magnetic Resonance Imaging
34%
Nerve Fiber
27%
Biological Marker
17%
Regression Analysis
10%
Retinal Disease
10%
Central Nervous System
10%
Ganglion Cell
10%
Microglia
10%
Visual Acuity
5%
Demyelinating Disease
5%
Oligoclonal Band
5%
In Vivo
5%
